| Structure | Chemical Name | CAS | MF |
|
CYCLICFATTYACIDS
|
|
|
|
|
cyclic AMP-regulated phosphoprotein 16
|
|
|
|
|
Cyclization
|
|
|
|
cyclic 1,N(2)-propanodeoxyguanosine
|
85352-97-2
|
C14H19N5O5
|
|
|
cyclic(arginyl-glycyl-aspartyl-seryl-prolyl-alanyl-seryl-serine)
|
|
|
|
|
cyclic (arginyl-glycyl-aspartyl-phenylalanyl-lysyl)
|
|
|
|
Cycliton
|
2433-20-7
|
C10H16N2O2
|
|
|
Cyclic-3(1,2-Ethamediyl-acetal)-estra-5(10)-ene-17-one
|
|
|
|
cyclic-2,3-diphosphoglycerate
|
88280-54-0
|
C3H6O9P2
|
|
|
Cyclizine
|
|
|
|
|
cyclic GMP-binding protein
|
|
|
|
|
CYCLINB1,RABBITANTI-HUMAN,FROZEN/PARAFFIN(W/NBREAG.)
|
|
|
|
|
cyclic lipoundecapeptide tensin
|
|
|
|
Cycliramine
|
47128-12-1
|
C18H19ClN2
|
|
|
cyclin F
|
|
|
|
Cyclizine
|
82-92-8
|
C18H22N2
|
|
|
cyclic AMP-specific phosphodiesterase PDE4A10
|
|
|
|
|
cyclic AMP receptor cAR1
|
|
|
|
|
cyclin-dependent kinase 8
|
|
|
|
|
CYCLICIMINES
|
|
|
|
|
CYCLINDEPENDENTKINASEINHIBITOR,P19INK4D,CLONE:DCS-100.1,MABANTI-HUMAN:PARAFFIN,IH/WB
|
|
|
|
|
CYCLINDEPENDENTKINASE2(CDK2),C-TERMINAL,33KD,RABBITANTI-HUMAN,MOUSE,RAT:IF/WB
|
|
|
|
Estradiene dione-3-keta
|
5571-36-8
|
C20H26O3
|
|
|
cyclic peptide 92-96C
|
|
|
|
|
CyclinB1PhosphorylatedAtSerine126
|
|
|
|
cyclic adenosine 3',5'-diphosphate
|
77319-01-8
|
C10H13N5O9P2
|
|
|
cyclic AMP-dependent phosphoprotein (rod outer segment)
|
|
|
|
|
CYCLIN-DEPENDENT KINASE FRAGMENT (151-169) FLUORESCEIN/AMIDE [HOMO SAPIENS]
|
|
C118H163N35O37S
|
|
|
CYCLICAMP(CAMP),RABBITANTI-HUMAN:RIA
|
|
|
|
|
cyclin B1-dependent kinase
|
|
|
|
|
cyclic beta(1-2) glucan synthetase
|
|
|
|
cyclic 9 beta-D-arabinosyladenine 3',5'-monophosphate
|
32465-18-2
|
C10H12N5O6P
|
|
|
Cyclical gravure printing ink
|
|
|
|
|
Cyclin-dependent Kinase 2 Inhibitor trifluoroacetate salt
|
|
|
|
|
Cyclin A primer set
|
|
|
|
|
cyclin-dependent kinase CDC2a
|
|
|
|
|
CyclinA
|
|
|
|
|
cyclin I
|
|
|
|
|
CYCLIND1,RABBITANTI-HUMAN,RAT
|
|
|
|
|
Cyclic GMP-Dependent Protein Kinases
|
|
|
|
|
CyclinCdk5(P31)DependentKinase
|
|
|
|
|
CyclinD2
|
|
|
|
|
CYCLIZINGAGENT-U
|
|
|
|
|
CyclinCdk2(P34)DependentKinase
|
|
|
|
|
cyclin B3
|
|
|
|
|
CYCLICGMP(CGMP),RABBITANTI-HUMAN:RIA
|
|
|
|
|
CYCLIND2,34KD,CLONES:DCS-3.1+DCS-5.2,MABANTI-HUMAN,MOUSE,RAT:IF/FLOW/KINASE/WB
|
|
|
|
|
Cyclin D1
|
136601-57-5
|
|
|
|
CYCLINDEPENDENTKINASE8(CDK8),C-TERMINAL,54KD,RABBITANTI-HUMAN,MOUSE,RAT:WB
|
|
|
|
|
Cyclin D primer set
|
|
|
|
|
Cyclin E primer set
|
|
|
|
|
Cyclical printing ink
|
|
|
|
|
CYCLIN-C,HUMAN,RECOMBINANT
|
|
|
|
|
cyclic ADP-ribose receptor
|
|
|
|
|
2',3'-cyclic nucleotide 2'-phosphodiesterase
|
9037-18-7
|
|
|
|
CYCLICFATTYACIDMONOMERS
|
|
|
|
|
cyclic(arginyl-alanyl-aspartyl-phenylalanyl-valyl)
|
|
|
|
|
CYCLINB,RECOMBINANT,62KD,WESTERNBLOTPOSITIVECONTROL
|
|
|
|
|
CYCLINA,CLONE:6E6,MABANTI-HUMAN:PARAFFIN,IH/WB
|
|
|
|
|
cyclin-dependent kinase 3
|
|
|
|
Cyclic cystathionine
|
105990-93-0
|
|
|
|
Cyclic phosphate(C=28)
|
|
|
|
|
Cyclindole hydrochloride
|
|
|
|
|
Cyclic carboxylic acid(nucleic mono and poly carboxylic acid including benzene ring,naphthalene ring,cyclopentane ring) salt(Na,K,Ca)
|
|
|
|
CYCLIZIDINE
|
84393-28-2
|
C17H25NO3
|
|
2',5'-CYCLIC METHYLPHOSPHONATE GUANOSINE
|
129546-31-2
|
C11H14N5O6P
|
|
|
Cybutryne Solution
|
|
|
|
Irgarol
|
28159-98-0
|
C11H19N5S
|
|
4-(cyclopentyloxy)-3-ethoxybenzoyl chloride
|
1160249-46-6
|
C14H17ClO3
|
|
{4-[(cyclopropylamino)sulfonyl]phenoxy}acetic acid
|
890094-43-6
|
C11H13NO5S
|
|
[2-(4-cyclohexylphenoxy)ethyl]amine hydrochloride
|
1048664-03-4
|
C14H22ClNO
|
|
(1-cyclopropylethyl)ethylamine
|
1017368-28-3
|
C7H15N
|
|
(1-cyclohexylpyrrolidin-3-yl)methanol
|
100049-71-6
|
C11H21NO
|
|
(1-cyclopropylethyl)methylamine
|
926200-63-7
|
C6H13N
|
|
(1-cyclopentylpyrrolidin-3-yl)methanol
|
1017429-88-7
|
C10H19NO
|
|
CYCLOPROPANECARBOXYLIC ACID, 1-FORMYL-, ETHYL ESTER
|
33329-70-3
|
C7H10O3
|
|
2-CYCLOHEXENE-1-CARBOXYLIC ACID, 2-METHYL-4-OXO-, METHYL ESTER
|
35490-07-4
|
C9H12O3
|
|
5-CYCLOPROPYLPYRIDIN-3-YLBORONIC ACID
|
1044210-58-3
|
C8H10BNO2
|
|
CYCLOPROPYL-ETHYL-AMINE OXALATE
|
24571-79-7
|
C5H11N.C2H2O4
|
|
CYCLOHEXANECARBONITRILE, 4-[[(1,1-DIMETHYLETHYL)DIPHENYLSILYL]OXY]-
|
141336-97-2
|
C23H29NOSi
|
|
CYCLOPROPANEMETHANOL, 1-HYDROXY-
|
42082-92-8
|
C4H8O2
|
|
CYCLOPENTANECARBOXYLIC ACID, 2-[[4'-[[(PHENYLAMINO)CARBONYL]AMINO][1,1'-BIPHENYL]-4-YL]CARBONYL]-, METHYL ESTER, (1R,2R)-
|
959122-10-2
|
C27H26N2O4
|
|
CYCLOPENTANECARBOXYLIC ACID, 2-(4-BROMOBENZOYL)-, METHYL ESTER, (1R,2R)-
|
791594-14-4
|
C14H15BrO3
|
|
CYCLOPENTANECARBOXYLIC ACID, 2-(4-BROMOBENZOYL)-, (1R,2R)-
|
791594-13-3
|
C13H13BrO3
|
|
CYCLOPROPANE-1,1-DICARBOXYLIC ACID DIMETHYL ESTER
|
151444-20-1
|
C7H10O4
|
|
CYCLO(RGDFK(SAA))
|
922175-70-0
|
C34H52N10O12
|
|
CYCLOHEXYLMETHYL-THIOUREA
|
66892-28-2
|
C8H16N2S
|
|
CYCLOPROPANECARBOXYLIC ACID, 1-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-2-ETHENYL-, (1S,2S)-
|
259221-77-7
|
C11H17NO4
|
|
CYCLOHEXANECARBOXYLIC ACID, 3-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-, (1R,3S)-
|
222530-39-4
|
C12H21NO4
|
|
CYCLOHEXANONE, 4-[[(1,1-DIMETHYLETHYL)DIPHENYLSILYL]OXY]-
|
130745-59-4
|
C22H28O2Si
|
|
4-CYCLOHEXYLOXY-PHENYLAMINE HYDROCHLORIDE
|
105971-50-4
|
C12H17NO.ClH
|
|
4-CYCLOPROPYL-3-OXO-BUTYRIC ACID METHYL ESTER
|
251635-21-9
|
C8H12O3
|
|
1-CYCLOPENTYL-3-METHYL-PIPERAZINE
|
163526-35-0
|
C10H20N2
|
|
3-CYCLOPENTYLACRYLONITRILE
|
591769-05-0
|
C8H11N
|
|
CYCLOPENTANEMETHANOL, 1-METHANSULFONATE
|
73017-76-2
|
C7H14O3S
|
|
CYCLOPROPANECARBOXAMIDE, 1-AMINO-N-(CYCLOPROPYLSULFONYL)-2-ETHENYL-, (1R,2S)-
|
772337-53-8
|
C9H14N2O3S
|
|
CYCLOHEXANECARBONITRILE, 4-OXO-
|
34916-10-4
|
C7H9NO
|
|
CYCLOHEXANECARBONITRILE, 4,4-DIFLUORO-
|
922728-21-0
|
C7H9F2N
|
|
CYCLOBUTANECARBOXYLIC ACID, 1-FORMYL-, ETHYL ESTER
|
57742-93-5
|
C8H12O3
|
|
CYCLOPENTANECARBOXYLIC ACID, 2-[(4'-AMINO[1,1'-BIPHENYL]-4-YL)CARBONYL]-, METHYL ESTER, (1R,2R)-
|
959123-13-8
|
C20H21NO3
|